BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26047923)

  • 1. The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson's Disease.
    Calandria JM; Sharp MW; Bazan NG
    Cell Mol Neurobiol; 2015 Nov; 35(8):1127-36. PubMed ID: 26047923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.
    Visanji NP; Orsi A; Johnston TH; Howson PA; Dixon K; Callizot N; Brotchie JM; Rees DD
    FASEB J; 2008 Jul; 22(7):2488-97. PubMed ID: 18364399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
    Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
    Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
    Nagel F; Bähr M; Dietz GP
    Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
    Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F
    Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons.
    Ahmadi FA; Linseman DA; Grammatopoulos TN; Jones SM; Bouchard RJ; Freed CR; Heidenreich KA; Zawada WM
    J Neurochem; 2003 Nov; 87(4):914-21. PubMed ID: 14622122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.
    Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR
    Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+).
    Koutsilieri E; Chan WW; Reinitzer D; Rausch WD
    J Neural Transm Gen Sect; 1993; 94(3):189-97. PubMed ID: 7907217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
    Lannuzel A; Michel PP; Höglinger GU; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch EC; Ruberg M
    Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures.
    Gearan T; Castillo OA; Schwarzschild MA
    Parkinsonism Relat Disord; 2001 Sep; 8(1):19-22. PubMed ID: 11472876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity.
    Ying R; Liang HL; Whelan HT; Eells JT; Wong-Riley MT
    Brain Res; 2008 Dec; 1243():167-73. PubMed ID: 18848925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited.
    Nakamura K; Bindokas VP; Marks JD; Wright DA; Frim DM; Miller RJ; Kang UJ
    Mol Pharmacol; 2000 Aug; 58(2):271-8. PubMed ID: 10908294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of rotigotine against complex I inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell culture.
    Radad K; Scheller D; Rausch WD; Reichmann H; Gille G
    Folia Neuropathol; 2014; 52(2):179-86. PubMed ID: 25118903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation.
    Ramachandiran S; Hansen JM; Jones DP; Richardson JR; Miller GW
    Toxicol Sci; 2007 Jan; 95(1):163-71. PubMed ID: 17018646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
    Grammatopoulos TN; Ahmadi F; Jones SM; Fariss MW; Weyhenmeyer JA; Zawada WM
    Brain Res; 2005 May; 1045(1-2):64-71. PubMed ID: 15910763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings.
    von Wrangel C; Schwabe K; John N; Krauss JK; Alam M
    Behav Brain Res; 2015 Feb; 279():52-61. PubMed ID: 25446762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.